Monopar Announces Encouraging Camsirubicin Phase 1b Trial Update

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 8/24/2026

1. NVDA
2. JMKE
3. SPY
4. BABA
5. REF
6. XPEV
7. USO
8. TSLA
9. REAX
10. CAPR

Go back to Monopar Announces Encouraging Camsirubicin Phase 1b Trial Update
(NASDAQ: MNPR) Delayed: 111.36 +3.64 (3.38%)
Previous Close $107.72    52 Week High $ 
Open $106.99    52 Week Low $ 
Day High $113.47    P/E N/A 
Day Low $104.48    EPS $ 
Volume 239,188